Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Poolbeg Pharma upbeat on preliminary influenza drug results

By: News Direct
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Poolbeg Pharma PLC (OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive after announcing initial data analysis, including a 'clear dose-related response', for its drug, POLB 001, a potential treatment for severe influenza. Skillington says the 'early data readout' indicates that the challenge trial was successful.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-upbeat-on-preliminary-influenza-drug-results-758545326

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  241.66
-2.53 (-1.04%)
AAPL  290.09
-0.46 (-0.16%)
AMD  470.01
-5.50 (-1.16%)
BAC  54.84
+0.42 (0.78%)
GOOG  364.38
+2.09 (0.58%)
META  585.43
+0.84 (0.14%)
MSFT  402.70
-0.71 (-0.18%)
NVDA  205.47
-2.72 (-1.31%)
ORCL  211.00
+5.19 (2.52%)
TSLA  390.07
-6.61 (-1.67%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.